Acceleration of robust "biotube" vascular graft fabrication by in-body tissue architecture technology using a novel eosin Y-releasing mold.

A novel eosin Y-releasing mold was designed to accelerate the fabrication of in vivo tissue engineered autologous vascular prosthetic tissues, called the "biotubes." The mold was prepared by addition of an aqueous solution of eosin Y (1∼6 w/v%) to the agar gel (0.3%), which was attached to the luminal surface of the microporous acrylate tube (diameter, 5 mm; length, 28 mm; pore size, 0.5 mmϕ). The eosin Y release period was controlled by the number of pores (3∼160). On embedding the molds into dorsal, subcutaneous pouches of rats for 1 week, completely encapsulated biotubes, mainly consisting of collagen, with thick walls (418.2 ± 173.4 μm) and robust mechanical properties (elastic modulus, 956.2 ± 196.5 kPa; burst pressure 5850 ± 2383 mmHg) were formed. These values were, respectively, more than 4.3, 3.8, and 5.6 times greater than the corresponding controls (acrylate rods). The high elastic modulus of the biotubes was obtained even with a small number of micropores (3), and a low concentration of eosin Y (1%) within a very short embedding period (5 days), irrespective of rat weights. This innovative method for rapid production of vascular grafts with thick walls and robust mechanical properties may be adaptable for the sub-emergency clinical use of biotubes in regenerative medicine.

[1]  J. Ando,et al.  In vitro maturation of "biotube" vascular grafts induced by a 2-day pulsatile flow loading. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  J. Fiddes,et al.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.

[3]  C. Vacanti,et al.  Bioengineered Three-Layered Robust and Elastic Artery Using Hemodynamically-Equivalent Pulsatile Bioreactor , 2008, Circulation.

[4]  Y. Nakayama,et al.  Development of the wing-attached rod for acceleration of "Biotube" vascular grafts fabrication in vivo. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[5]  S. Omata,et al.  Improvement of hydrogelation abilities and handling of photocurable gelatin-based crosslinking materials. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[6]  Laura E Niklason,et al.  Decellularized tissue-engineered blood vessel as an arterial conduit , 2011, Proceedings of the National Academy of Sciences.

[7]  Ali Khademhosseini,et al.  Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. , 2006, Biomaterials.

[8]  H. Mertsching,et al.  Tissue engineering human small-caliber autologous vessels using a xenogenous decellularized connective tissue matrix approach: preclinical comparative biomechanical studies. , 2011, Artificial organs.

[9]  Y. Nakayama,et al.  Long-term animal implantation study of biotube-autologous small-caliber vascular graft fabricated by in-body tissue architecture. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  Y. Nakayama,et al.  In situ hydrogelation of photocurable gelatin and drug release. , 2002, Journal of biomedical materials research.

[11]  Yasuhide Nakayama,et al.  In Vivo Tissue-Engineered Small-Caliber Arterial Graft Prosthesis Consisting of Autologous Tissue (Biotube) , 2004, Cell transplantation.

[12]  Y. Nakayama,et al.  Development of high-performance stent: gelatinous photogel-coated stent that permits drug delivery and gene transfer. , 2001, Journal of biomedical materials research.

[13]  Yoshiki Sawa,et al.  In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding. , 2008, The Journal of thoracic and cardiovascular surgery.

[14]  H. Iida,et al.  3-Tesla magnetic resonance angiographic assessment of a tissue-engineered small-caliber vascular graft implanted in a rat. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[15]  C. Heeschen,et al.  Nicotine promotes arteriogenesis. , 2003, Journal of the American College of Cardiology.

[16]  Yasuhide Nakayama,et al.  Faster and stronger vascular "Biotube" graft fabrication in vivo using a novel nicotine-containing mold. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[17]  J. Isner,et al.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.

[18]  T Matsuda,et al.  Vascular Endothelial Growth Factor Enhances Vascularization in Microporous Small Caliber Polyurethane Grafts , 1997, ASAIO journal.

[19]  Y. Nakayama,et al.  Newly designed hemostatic technology based on photocurable gelatin. , 1995, ASAIO journal.

[20]  Y. Nakayama,et al.  Photocurable surgical tissue adhesive glues composed of photoreactive gelatin and poly(ethylene glycol) diacrylate. , 1999, Journal of biomedical materials research.

[21]  Yasuhide Nakayama,et al.  Autologous small-caliber "biotube" vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[22]  B. Lévy,et al.  Vascular Endothelial Growth Factor‐B Promotes In Vivo Angiogenesis , 2003, Circulation research.

[23]  Narutoshi Hibino,et al.  Late-term results of tissue-engineered vascular grafts in humans. , 2010, The Journal of thoracic and cardiovascular surgery.